Exela sodium bicarbonate injection recalled due to potential for flying glass 

Oct 14, 2022 - 04:04 PM
syringe-recall

Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration, causing glass to fly. Exela has received five reports of injury from flying glass. The drug is used to treat metabolic acidosis.

Related News Articles

Headline
FDA announces firm distributing Chinese-made plastic syringes in the U.S. initiates recall 
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Headline
FDA issues import alert, additional recommendations against using plastic syringes made in China 
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
FDA advises against using plastic syringes made in China
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
FDA adds vaporized hydrogen peroxide as an established medical device sterilization method 
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…